Impact of Modifiable Bleeding Risk Factors on Major Bleeding in Patients With Atrial Fibrillation Anticoagulated With Rivaroxaban

BACKGROUND: Reducing major bleeding events is a challenge when managing anticoagulation in patients with atrial fibrillation. This study evaluated the impact of modifiable and nonmodifiable bleeding risk factors in patients with atrial fibrillation receiving rivaroxaban and estimated the impact of r...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Am Heart Assoc
Autors principals: Kirchhof, Paulus, Haas, Sylvia, Amarenco, Pierre, Hess, Susanne, Lambelet, Marc, van Eickels, Martin, Turpie, Alexander G. G., Camm, A. John
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2020
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7335544/
https://ncbi.nlm.nih.gov/pubmed/32079476
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.118.009530
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars